[MYGN] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
03-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -28.81%
YoY- -87.12%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 164,000 216,600 193,500 196,900 190,500 179,985 182,924 -1.80%
PBT -131,100 3,300 16,500 8,000 43,100 35,566 57,343 -
Tax -15,900 -3,600 5,200 3,800 10,500 14,091 20,573 -
NP -115,200 6,900 11,400 4,200 32,600 21,475 36,770 -
Tax Rate - 109.09% -31.52% -47.50% -24.36% -39.62% -35.88% -
Total Cost 279,200 209,700 182,100 192,700 157,900 158,510 146,154 11.38%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -70.24 3.19 5.89 2.13 17.11 11.93 20.10 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -1.55 0.09 0.16 0.06 0.49 0.30 0.50 -
EPS Diluted -1.55 0.09 0.16 0.06 0.47 0.29 0.48 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.